Aaron Wealth Advisors LLC Purchases New Shares in Synopsys, Inc. $SNPS

Aaron Wealth Advisors LLC purchased a new position in Synopsys, Inc. (NASDAQ:SNPSFree Report) during the 1st quarter, HoldingsChannel.com reports. The fund purchased 1,503 shares of the semiconductor company’s stock, valued at approximately $596,000.

A number of other institutional investors have also added to or reduced their stakes in SNPS. Sankala Group LLC purchased a new position in Synopsys during the fourth quarter valued at $25,000. Thurston Springer Miller Herd & Titak Inc. purchased a new stake in shares of Synopsys in the 4th quarter worth about $28,000. Caitong International Asset Management Co. Ltd bought a new position in shares of Synopsys in the 4th quarter worth about $28,000. Atlas Capital Advisors Inc. purchased a new position in Synopsys during the 4th quarter valued at about $32,000. Finally, Osbon Capital Management LLC purchased a new position in Synopsys during the 4th quarter valued at about $34,000. Institutional investors own 85.47% of the company’s stock.

Synopsys Price Performance

NASDAQ SNPS opened at $454.34 on Friday. Synopsys, Inc. has a one year low of $376.18 and a one year high of $651.73. The stock has a 50-day moving average of $483.67 and a 200 day moving average of $462.15. The company has a market capitalization of $87.00 billion, a price-to-earnings ratio of 105.17, a PEG ratio of 2.67 and a beta of 1.22. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.32 and a current ratio of 1.43.

Synopsys (NASDAQ:SNPSGet Free Report) last issued its earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts’ consensus estimates of $3.15 by $0.20. The business had revenue of $2.28 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.Synopsys’s revenue was up 41.9% on a year-over-year basis. During the same quarter in the previous year, the firm earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. On average, sell-side analysts forecast that Synopsys, Inc. will post 10.65 EPS for the current year.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction that occurred on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the completion of the sale, the chief financial officer owned 14,358 shares of the company’s stock, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the business’s stock in a transaction on Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 0.56% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on SNPS shares. Wells Fargo & Company upped their price objective on shares of Synopsys from $505.00 to $535.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. BNP Paribas Exane lifted their target price on shares of Synopsys from $425.00 to $450.00 and gave the company an “underperform” rating in a report on Thursday, May 28th. Weiss Ratings reissued a “hold (c-)” rating on shares of Synopsys in a research report on Monday, June 8th. Morgan Stanley upped their price target on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a research note on Thursday, May 28th. Finally, Stifel Nicolaus raised their price objective on Synopsys from $550.00 to $600.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. Ten equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $570.06.

View Our Latest Analysis on Synopsys

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Articles

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPSFree Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.